Iron Financial LLC lessened its position in CME Group Inc. (NASDAQ:CME) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 88,606 shares of the financial services provider’s stock after selling 450 shares during the quarter. CME Group comprises about 8.1% of Iron Financial LLC’s investment portfolio, making the stock its 3rd biggest position. Iron Financial LLC’s holdings in CME Group were worth $16,131,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Tarbox Family Office Inc. grew its position in CME Group by 75.5% in the 3rd quarter. Tarbox Family Office Inc. now owns 193 shares of the financial services provider’s stock worth $32,000 after purchasing an additional 83 shares during the last quarter. Rockbridge Investment Management LCC grew its position in CME Group by 1,663.6% in the 3rd quarter. Rockbridge Investment Management LCC now owns 194 shares of the financial services provider’s stock worth $32,000 after purchasing an additional 183 shares during the last quarter. Paces Ferry Wealth Advisors LLC acquired a new stake in CME Group in the 3rd quarter worth $33,000. CVA Family Office LLC acquired a new stake in CME Group in the 3rd quarter worth $38,000. Finally, Eudaimonia Partners LLC grew its position in CME Group by 67.9% in the 3rd quarter. Eudaimonia Partners LLC now owns 225 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 91 shares during the last quarter. Hedge funds and other institutional investors own 83.88% of the company’s stock.

Shares of NASDAQ CME traded down $3.54 during trading on Wednesday, reaching $197.95. The company had a trading volume of 1,973,820 shares, compared to its average volume of 2,154,265. CME Group Inc. has a 52 week low of $131.80 and a 52 week high of $225.36. The stock has a market cap of $71.06 billion, a PE ratio of 33.58, a PEG ratio of 15.03 and a beta of 0.46. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business’s 50 day moving average price is $182.73 and its 200-day moving average price is $170.44.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 28th. The financial services provider reported $1.38 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.41 by ($0.03). CME Group had a return on equity of 9.22% and a net margin of 43.68%. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the firm posted $1.90 earnings per share. Equities analysts anticipate that CME Group Inc. will post 6.73 earnings per share for the current year.

The business also recently announced a None dividend, which will be paid on Wednesday, January 13th. Shareholders of record on Monday, December 28th will be paid a $2.50 dividend. The ex-dividend date of this dividend is Thursday, December 24th. CME Group’s dividend payout ratio is presently 50.00%.

Several analysts have recently weighed in on CME shares. JPMorgan Chase & Co. upgraded shares of CME Group from an “underweight” rating to a “neutral” rating and lifted their target price for the company from $138.00 to $203.00 in a research report on Thursday, January 7th. BidaskClub upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a research report on Sunday, November 29th. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and set a $196.00 target price on the stock. in a research report on Friday, January 8th. They noted that the move was a valuation call. Rosenblatt Securities decreased their target price on shares of CME Group from $140.00 to $135.00 and set a “sell” rating on the stock in a research report on Wednesday, January 6th. Finally, Zacks Investment Research lowered shares of CME Group from a “buy” rating to a “hold” rating and set a $205.00 target price on the stock. in a research report on Thursday, January 7th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $188.06.

In related news, insider Ken Vroman sold 4,541 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $152.63, for a total transaction of $693,092.83. Following the completion of the sale, the insider now directly owns 9,879 shares of the company’s stock, valued at $1,507,831.77. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO John W. Pietrowicz sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 1st. The stock was sold at an average price of $180.00, for a total transaction of $900,000.00. Following the sale, the chief financial officer now directly owns 44,830 shares of the company’s stock, valued at $8,069,400. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,100 shares of company stock valued at $2,960,709. Insiders own 1.20% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Featured Story: What does an equal weight rating mean?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.